Literature DB >> 10595458

Expression of the cadherin-catenin complex in well-differentiated human thyroid neoplastic tissue.

S H Huang1, J C Wu, K J Chang, K Y Liaw, S M Wang.   

Abstract

E-cadherin is a member of the cadherin family that plays a major role in epithelial integrity and tumorigenesis. Catenins are a group of cytoplasmic proteins that regulate the intracellular anchorage of cadherin and are required for the linkage between cadherin and the actin cytoskeleton. Loss of E-cadherin contributes to the pathogenesis in tumor invasion and gives a poor prognosis. In order to investigate the adhesion property of intercellular junctions in thyroid tumors, expression of alpha-,beta, and gamma-catenin should also be studied. A correlation between these molecular markers and malignancy would be useful as a preoperative diagnostic test for thyroid neoplasms. The expression of E-cadherin, alpha-, beta-, and gamma-catenin were studied in normal and neoplastic thyroid tissue by immunofluorescence microscopy and Western blot analysis. In the normal thyroid and in nodular goiter, and follicular adenoma, staining for E-cadherin, alpha-, beta-, and gamma-catenin was seen mainly at the lateral surface of epithelial cells in the follicle and the presence of these molecules was confirmed by Western blot analysis. Follicular carcinoma tissue stained positive for E-cadherin and alpha-catenin, but the results of beta- and gamma-catenin immunostaining were highly variable, with beta-catenin being absent in most follicular carcinomas (8/10) and gamma-catenin being absent in some follicular carcinomas (3/10). These results suggest that E-cadherin expression was not reduced during the pathogenesis of differentiated thyroid malignancies. Impairment of the cadherin-catenin complex at the cell junction may contribute to the malignant progression of differentiated thyroid neoplastic tissue.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10595458     DOI: 10.1089/thy.1999.9.1095

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  4 in total

1.  Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis.

Authors:  G Garcia-Rostan; R L Camp; A Herrero; M L Carcangiu; D L Rimm; G Tallini
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

2.  Analysis of beta-catenin mutations and alpha-, beta-, and gamma-catenin expression in normal and neoplastic human pituitary tissues.

Authors:  V Tziortzioti; K H Ruebel; T Kuroki; L Jin; B W Scheithauer; R V Lloyd
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

3.  Immunohistochemical detection of E-cadherin, alpha- and beta-catenins in papillary thyroid carcinoma.

Authors:  Y Kapran; N Ozbey; S Molvalilar; E Sencer; F Dizdaroğlu; S Ozarmağan
Journal:  J Endocrinol Invest       Date:  2002 Jul-Aug       Impact factor: 4.256

4.  Wnt/β-catenin signaling plays an ever-expanding role in stem cell self-renewal, tumorigenesis and cancer chemoresistance.

Authors:  Maryam K Mohammed; Connie Shao; Jing Wang; Qiang Wei; Xin Wang; Zachary Collier; Shengli Tang; Hao Liu; Fugui Zhang; Jiayi Huang; Dan Guo; Minpeng Lu; Feng Liu; Jianxiang Liu; Chao Ma; Lewis L Shi; Aravind Athiviraham; Tong-Chuan He; Michael J Lee
Journal:  Genes Dis       Date:  2016-01-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.